Charanjit Aulakh

Array ( [id] => 5769371 [patent_doc_number] => 20060019983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/202115 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16342 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019983.pdf [firstpage_image] =>[orig_patent_app_number] => 11202115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607495 [patent_doc_number] => 07098221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'Amide substituted imidazopyridines' [patent_app_type] => utility [patent_app_number] => 11/200556 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25490 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098221.pdf [firstpage_image] =>[orig_patent_app_number] => 11200556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759534 [patent_doc_number] => 20060210479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Targeting chelants and chelates' [patent_app_type] => utility [patent_app_number] => 11/201852 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 36138 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210479.pdf [firstpage_image] =>[orig_patent_app_number] => 11201852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84162 [patent_doc_number] => 07741487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Method for producing quaterrylene-3,4:13, 14-tetracarboxy diimides by direct synthesis' [patent_app_type] => utility [patent_app_number] => 11/573948 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5765 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741487.pdf [firstpage_image] =>[orig_patent_app_number] => 11573948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591538 [patent_doc_number] => 20060040990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Epothilone derivatives, process for their production, and their pharmaceutical use' [patent_app_type] => utility [patent_app_number] => 11/189787 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44493 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040990.pdf [firstpage_image] =>[orig_patent_app_number] => 11189787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978602 [patent_doc_number] => 20050288320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'IMIDAZONAPHTHYRIDINES' [patent_app_type] => utility [patent_app_number] => 11/188418 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42985 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288320.pdf [firstpage_image] =>[orig_patent_app_number] => 11188418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630572 [patent_doc_number] => 07132533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy' [patent_app_type] => utility [patent_app_number] => 11/187089 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118745 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132533.pdf [firstpage_image] =>[orig_patent_app_number] => 11187089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225639 [patent_doc_number] => 20070254906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Method of Administration of Dopamine Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/632874 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29831 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254906.pdf [firstpage_image] =>[orig_patent_app_number] => 11632874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214299 [patent_doc_number] => 08193175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Ruthenium complexes for treating cancers' [patent_app_type] => utility [patent_app_number] => 11/631979 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 12587 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193175.pdf [firstpage_image] =>[orig_patent_app_number] => 11631979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601726 [patent_doc_number] => 07384976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/135418 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27969 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384976.pdf [firstpage_image] =>[orig_patent_app_number] => 11135418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739088 [patent_doc_number] => 20060009479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Process for the synthesis of hydromorphone' [patent_app_type] => utility [patent_app_number] => 11/178717 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5792 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009479.pdf [firstpage_image] =>[orig_patent_app_number] => 11178717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794089 [patent_doc_number] => 20060014770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Therapeutic compound and treatments' [patent_app_type] => utility [patent_app_number] => 11/179796 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17662 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014770.pdf [firstpage_image] =>[orig_patent_app_number] => 11179796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837139 [patent_doc_number] => 07393955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Isoquinoline derivatives and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/177161 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21865 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393955.pdf [firstpage_image] =>[orig_patent_app_number] => 11177161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250866 [patent_doc_number] => 20050272774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Substituted cyclohexane derivatives' [patent_app_type] => utility [patent_app_number] => 11/176901 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31292 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272774.pdf [firstpage_image] =>[orig_patent_app_number] => 11176901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926460 [patent_doc_number] => 20050239716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => '2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives' [patent_app_type] => utility [patent_app_number] => 11/172146 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19717 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239716.pdf [firstpage_image] =>[orig_patent_app_number] => 11172146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5019387 [patent_doc_number] => 20070145353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Phenanthroline derivative and light emitting element and light emitting device using the same' [patent_app_type] => utility [patent_app_number] => 10/579114 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10637 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20070145353.pdf [firstpage_image] =>[orig_patent_app_number] => 10579114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995167 [patent_doc_number] => 20070010512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs' [patent_app_type] => utility [patent_app_number] => 11/167488 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9543 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010512.pdf [firstpage_image] =>[orig_patent_app_number] => 11167488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803347 [patent_doc_number] => 07423051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => '2,6-diaminopyridine derivatives' [patent_app_type] => utility [patent_app_number] => 11/165912 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14468 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423051.pdf [firstpage_image] =>[orig_patent_app_number] => 11165912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614436 [patent_doc_number] => 20060116364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Selective estrogen receptor modulator' [patent_app_type] => utility [patent_app_number] => 11/158245 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 189678 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116364.pdf [firstpage_image] =>[orig_patent_app_number] => 11158245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769346 [patent_doc_number] => 20060019978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Spirocyclic compounds useful as modulators of nuclear hormone receptor function' [patent_app_type] => utility [patent_app_number] => 11/157040 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17020 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019978.pdf [firstpage_image] =>[orig_patent_app_number] => 11157040 [rel_patent_id] =>[rel_patent_doc_number] =>)